Current Protocols Editorial Board: Human Genetics

Current Protocols Web Advisory Panel


 

Jonathan L. Haines
Jonathan L. Haines received his Doctorate in Genetics from the University of Minnesota in 1984. He is currently the Chief for the Division of Human Genomics and the T. H. Morgan Professor of Human Genetics at Vanderbilt University. Dr. Haines has delivered over 90 invited lectures across the U.S. and around the world, as well as having more than 400 articles, reviews, and book chapters to his credit. He has contributed to various editorial boards, including currently serving as senior editor for the Annals of Human Genetics and as an editor for Current Protocols in Human Genetics. Dr. Haines has 7 patents pending related to his recent research, which has focused on the genetics of such complex diseases as multiple sclerosis, age-related macular degeneration, and Alzheimer's disease. Since 2003, he has been the Director of Vanderbilt's Center for Human Genetics Research. 

Bruce R. Korf
Dr. Korf received his M.D. degree from Cornell University Medical College and his Ph.D. degree in genetics and cell biology from Rockefeller University. He then completed training in pediatrics, pediatric neurology, and genetics at Children's Hospital, Boston. He served as clinical director in the Division of Genetics at Children's Hospital from 1986 to 1999 and as the medical director of the Harvard-Partners Center for Genetics and Genomics from 1999-2002. Currently he is the Wayne H. and Sara Crews Finley Professor of Genetics and Chairman, Department of Genetics at University of Alabama at Birmingham. In his previous appointment at Harvard Medical School he served as co-director of the course Genetics, Developmental and Reproductive Biology, taught to all first year students at Harvard Medical School. His book based on this course, Human Genetics: A Problem-Based Approach, published by Blackwell Science is currently in its third edition. He is also co-editor of the fifth edition of Emery and Rimoin's Principles and Practice of Medical Genetics, and co-editor of Current Protocols in Human Genetics. Dr. Korf is President-Elect of the American College of Medical Genetics. He has completed terms as president of the Association of Professors of Human and Medical Genetics, member of the boards of directors of the American College of Medical Genetics and the American Society of Human Genetics, and member of the Liaison Committee on Medical Education. He currently serves on the National Cancer Institute Board of Scientific Counselors.

 Website: http://138.26.61.118/depts/MEB/SOMResearchFaculty/currentfacultydata.asp?ID=bkorf  

Cynthia Casson Morton
Cynthia Casson Morton received her Bachelor's of Science degree from the College of William and Mary in Virginia and her Ph.D. in Human Genetics from the Medical College of Virginia in Richmond. She is the William Lambert Richardson Professor of Obstetrics, Gynecology and Reproductive Biology and Professor of Pathology at Harvard Medical School, Associate Director of the Harvard-Partners Center for Genetics and Genomics, and Co-Director of the Biomedical Research Institute and Director of Cytogenetics at Brigham and Women's Hospital. Dr. Morton is certified by the American Board of Medical Genetics in Ph.D. Medical Genetics, Clinical Cytogenetics and Clinical Molecular Genetics. Her research interests are in molecular cytogenetics, hereditary deafness, genetics of uterine leiomyomata and human developmental disorders.

As Director of Cytogenetics, Dr. Morton oversees one of the largest full-service academic cytogenetics laboratories in the country. This laboratory has been at the forefront in implementing molecular methods in diagnostic testing for chromosome studies that cross the lifespan. These tests include preimplantation and prenatal diagnostics, perinatal and childhood studies in the evaluation of congenital and developmental disorders, infertility and pregnancy loss studies, and cytogenetics of leukemias, lymphomas and solid tumors. Her laboratory has been a major site for training laboratory geneticists in clinical cytogenetics.

 Dr. Morton is a past member of the Board of Directors of the American Board of Medical Genetics where she served as Secretary, Treasurer and Chair of the Accreditation Committee. She was the Chair of the Molecular Genetic Pathology Policy and Exam Committees of the American Board of Medical Genetics and the American Board of Pathology. She served as a member and Chair of the Board of Scientific Counselors of the National Institute of Deafness and Other Communication Disorders. Currently she is a member of the Counsel of Scientific Trustees of the Deafness Research Foundation and serves as Chair of the Board of Regents of the National Library of Medicine at the National Institutes of Health. Dr. Morton is Editor of The American Journal of Human Genetics.

 Website: http://www.hms.harvard.edu/dms/bbs/fac/morton.html  

Christine E. Seidman
Christine Seidman's laboratory discovers gene mutations that cause human disease, with a focus on cardiovascular conditions such as cardiomyopathy (hypertrophic and dilated), heart failure, and congenital heart malformations. Her laboratory also produces model organisms that carry human mutations, and uses these models to determine how responses to gene mutations perturb or influence myocardial structure and specialized heart functions. 

J.G. Seidman
Dr. J.G. Seidman is the Henrietta B. and Frederick H. Bugher Foundation Professor of Genetics at Harvard Medical School. He received his undergraduate degree from Harvard University ('72) and his Ph.D. degree form the University of Wisconsin-Madison. His postdoctoral studies were carried out in Dr. Philip Leder's laboratory at the National Institute of Child Health and Human Development. He has been a member of the Genetics Department, Harvard Medical School since 1981. Over the past ten years his research has been directed towards understanding the molecular basis and epidemiology of hypertrophic cardiomyopathy, dilated cardiomyopathy and congenital heart disease.

 Dr. Seidman is a member of The Genetics Society of America and the American Society of Human Genetics. He has received several awards including the Gill Heart Institute Award for Outstanding Contributions to Cardiovascular Research (2000), the 12th Annual Bristol-Myers Squibb Award for Distinguished Achievement in Cardiovascular Research (2002) jointly with Christine Seidman, MD and the Lefoulon-Delalande Foundation, Grand Prix for Science (2007) joint recipient with Christine Seidman, MD. He is also a member of the National Academy of Science (2007) and the Institutes of Medicine (2007).

 Website: http://genetics.med.harvard.edu/~seidman/  

Douglas R. Smith
Dr. Smith completed his Ph.D. at Cornell University in 1981. At Collaborative Research, Inc., he helped construct the first human genetic linkage map and developed improved technologies for PFGE, large insert cloning and multiplex sequencing. He produced the first commercially generated genome sequence (of H. pylori) in 1995 and contributed to bioinformatics development at Genome Therapeutics Corp. (renamed from CRI). Dr. Smith helped establish technologies for gene expression microarrays, capillary electrophoresis, SNP genotyping and micro-scale sample handling. As Director of the GTC Sequencing Center, he made substantial contributions to the NHGRI-funded sequencing and analysis of the human, mouse and rat genomes. Continuing at Agencourt Bioscience Corp., Dr. Smith led efforts to sequence of numerous additional large genomes, to produce the first sequence based structural variation map of the human genome, and helped develop the SOLiD next-generation sequencing technology. He has published over 55 research articles, and has made numerous presentations at international conferences.